Detalhe da pesquisa
1.
Evaluation of terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury using point-of-care echocardiography.
Hepatology
; 79(5): 1048-1064, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37976391
2.
Growth Hormone Therapy in Decompensated Cirrhosis: An Open-Label, Randomized Control Trial.
Am J Gastroenterol
; 119(1): 116-126, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37115908
3.
Endoscopic Ultrasound-Guided Transgastric Shunt Obliteration for Recurrent Hepatic Encephalopathy.
Am J Gastroenterol
; 118(10): 1895-1898, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37589493
4.
Lean Indian patients with non-alcoholic fatty liver disease (NAFLD) have less metabolic risk factors but similar liver disease severity as non-lean patients with NAFLD.
Int J Obes (Lond)
; 47(10): 986-992, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37474570
5.
Efficacy and safety of pan-genotypic sofosbuvir and velpatasvir in patients with hepatitis C and HIV coinfection on dolutegravir-based antiretroviral therapy.
J Viral Hepat
; 30(9): 740-745, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37260083
6.
Assessment of Sarcopenia Using Muscle Ultrasound in Patients With Cirrhosis and Sarcopenic Obesity (AMUSE STUDY).
J Clin Gastroenterol
; 57(8): 841-847, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35943413
7.
Machine learning can guide suitability of consultation and patient referral through telemedicine for hepatobiliary diseases.
J Gastroenterol Hepatol
; 38(6): 999-1007, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37114643
8.
Home-based intensive nutrition therapy improves frailty and sarcopenia in patients with decompensated cirrhosis: A randomized clinical trial.
J Gastroenterol Hepatol
; 38(2): 210-218, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36268614
9.
Prevalence, Risk Factors, and Impact of Bacterial or Fungal Infections in Acute Liver Failure Patients from India.
Dig Dis Sci
; 68(10): 4022-4038, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37578566
10.
Antibody Response and Safety of ChAdOx1-nCOV (Covishield) in Patients with Cirrhosis: A Cross-Sectional, Observational Study.
Dig Dis Sci
; 68(2): 676-684, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36156752
11.
Association of Heparin-Like Effect, Factor VII/XIII Deficiency and Fibrinolysis with Rebleeding Risk in Cirrhosis with Acute Variceal Bleeding.
Dig Dis Sci
; 68(2): 497-513, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35984611
12.
Poor Performance of Non-invasive Tests for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: A Multicentric Asian Study.
Dig Dis Sci
; 68(12): 4485-4498, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37733130
13.
Improvement of chronic HCV infection-related depression, anxiety, and neurocognitive performance in persons achieving SVR-12: A real-world cohort study.
J Viral Hepat
; 29(5): 395-406, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35266624
14.
Sofosbuvir plus velpatasvir combination for the treatment of chronic hepatitis C in patients with end stage renal disease on renal replacement therapy: A systematic review and meta-analysis.
Nephrology (Carlton)
; 27(1): 82-89, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34453374
15.
Multiple Cycles of Granulocyte Colony-Stimulating Factor Increase Survival Times of Patients With Decompensated Cirrhosis in a Randomized Trial.
Clin Gastroenterol Hepatol
; 19(2): 375-383.e5, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32088302
16.
Sofosbuvir and Velpatasvir combination is safe and effective in treating chronic hepatitis C in end-stage renal disease on maintenance haemodialysis.
Liver Int
; 41(4): 705-709, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33025685
17.
Impact of metabolic risk factors on the severity and outcome of patients with alcohol-associated acute-on-chronic liver failure.
Liver Int
; 41(1): 150-157, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32970356
18.
Metabolic dysfunction-associated steatotic liver disease (MASLD) definition is better than MAFLD criteria for lean patients with NAFLD.
J Hepatol
; 80(2): e61-e62, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37558135
19.
Outcomes after multiple courses of granulocyte colony-stimulating factor and growth hormone in decompensated cirrhosis: A randomized trial.
Hepatology
; 68(4): 1559-1573, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29278428
20.
Fingolimod, a sphingosine-1-phosphate agonist for the treatment of hepatopulmonary syndrome: Queries and concerns.
J Hepatol
; 79(5): e193-e194, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37146887